The dramatic rise and spectacular fall of my ChatGPT investment portfolio
Briefly

The dramatic rise and spectacular fall of my ChatGPT investment portfolio
"When I asked ChatGPT to pick a portfolio of five high-growth stocks back in September, it spent almost 10 minutes doing research before returning its picks. The five it chose were Palantir, AppLovin, MicroStrategy, Agios Pharmaceuticals, and Hut 8. The bot felt that Palantir and AppLovin had strong, AI-powered businesses that would continue to dominate their markets and grow. Agios Pharma, the bot reported, was awaiting the results of an FDA trial for a new drug."
"Since then, it's been a wild ride. My portfolio has flown to new heights, giving me serious FOMO about the fact that I didn't put all my money into ChatGPT's picks. Then, it singed its wings, falling Icarus-style to lows that had me almost ready to bail on the whole thing and redirect the charred remains of my money to the kind of boring stuff (car payments, dental work) that I probably should have used it for in the first place."
"Three months ago, I fired up ChatGPT and asked it to design a highly aggressive, short-term investment portfolio, selecting five stocks that were most likely to make me fabulously wealthy in six month's time. Then, I threw good sense to the wind, transferred $500 of my actual money into a Robinhood account, and bought the stocks that ChatGPT had pitched. Since then, it's been a wild ride."
A $500 investment was placed into a five-stock, highly aggressive portfolio selected by ChatGPT and bought on Robinhood. The chosen names were Palantir, AppLovin, MicroStrategy, Agios Pharmaceuticals, and Hut 8. Rationale included AI-driven growth for Palantir and AppLovin, a pending FDA trial as a catalyst for Agios, and leveraged Bitcoin exposure via MicroStrategy and Hut 8. The portfolio experienced rapid gains followed by steep declines, demonstrating significant volatility. The experiment is at the halfway point of a six-month timeframe. A clear risk of losing most of the investment remains, and professional advice is recommended.
Read at Fast Company
Unable to calculate read time
[
|
]